A novel, soluble, liquid glucagon formulation that is stable for at least 2 years at room temperature is in development for severe hypoglycemia rescue (Fig. 1).17 This formulation is accomplished through a nonaqueous platform technology that inhibits glucagon fibrillation and provides enhanced stability and full portability. Here, GCG is linked to Hypoglycemia.